AAPL 170.33 +0.29 (+0.17%)MSFT 108.2 +0.55 (+0.51%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 170.33 +0.29 (+0.17%)MSFT 108.2 +0.55 (+0.51%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Balance Sheet ANAB Quote AnaptysBio

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 52 51 81
ShortTermInvest 0 0 167
Cash 52 51 248
AccountReceivab 1 5 2
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 53 58 253
PPE 4 4 5
AccumulatedDepr -4 -4 -4
NetPPE 1 0 1
EquityAndOtherI 0 0 76
Goodwill 0 0 0
IntangibleAsset 0 0 0
OtherLTAssets 2 4 0
TotalNonCurrent 3 4 77
TotalAssets 56 62 329
ShortTermDebt 0 0 7
AccountsPayable 2 2 2
TaxesPayable 0 0 0
AccruedLiabilit 3 3 5
DeferredRevenue 3 0 0
OtherCurrentLia 0 0 0
TotalCurrentLia 7 6 14
Debt 5 14 8
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 79 81 0
TotalNonCurrent 84 95 8
TotalLiabilitie 91 100 22
CommonStock 0 0 0
AdditionalPaidI 15 17 393
RetainedEarning -51 -55 -85
AccumulatedOthe 0 -78 0
TotalStockholde -35 -38 308
TotalLiabilitie 56 62 329
AnaptysBio Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AnaptysBio Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.